27 January 2021 : Clinical Research
Percentage of Natural Killer (NK) Cells in Peripheral Blood Is Associated with Prognosis in Patients with Gastric Cancer: A Retrospective Study from a Single Center
Ming-zhi XieBCE, Yan-ping TangBDE, Bang-li HuCE, Ke-zhi LiCDE, Ji-lin LiBCD, Xin-qiang LiangAEGDOI: 10.12659/MSM.927464
Med Sci Monit 2021; 27:e927464
Table 4 Association of percentage of NK cells with the clinical features of gastric cancer patients.
| Variables | NK cell | P value |
|---|---|---|
| Age | 0.803 | |
| >60 years | 13.06±10.62 | |
| ≤60 years | 12.65±9.51 | |
| Gender | 0.118 | |
| Male | 11.90±10.45 | |
| Female | 14.41±9.11 | |
| Location | 0.580 | |
| Antrum | 13.06±10.03 | |
| Body | 14.75±11.64 | |
| Cardiac | 10.53±8.72 | |
| Fundus | 10.23±8.92 | |
| Differentiation | 0.365 | |
| Low | 13.87±9.92 | |
| Middle | 10.86±9.44 | |
| High | 18.47±13.75 | |
| T stage | 0.018 | |
| T1+T2 | 17.08±11.70 | |
| T3+T4 | 11.69±9.22 | |
| N stage | 0.033 | |
| N0 | 16.61±12.22 | |
| NI+N2+N3 | 11.73±9.03 | |
| M stage | 0.101 | |
| M0 | 10.30±10.42 | |
| M1 | 13.59±9.81 | |
| Clinical stage | 0.010 | |
| I+II | 16.87±10.95 | |
| III+IV | 11.57±9.39 |